# Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

> **NCT05722262** · PHASE1 · COMPLETED · sponsor: **Kowa Research Institute, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** K-001
- **DRUG:** K-877-ER
- **DRUG:** CSG452

## Key facts

- **NCT ID:** NCT05722262
- **Lead sponsor:** Kowa Research Institute, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-24
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-04-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05722262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05722262, "Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05722262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*